A Four-in-one First-in-human Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Concentration-Qtc Relationship of HRS-1780, a Selective Non-Steroidal Mineralocorticoid Receptor Antagonist, in Healthy Men.
Expert Opinion on Investigational Drugs(2024)
关键词
First-in-human study,four-in-one,healthy men,HRS-1780,selective non-steroidal mineralocorticoid receptor antagonist
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要